Evolva

About:

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

Website: http://www.evolva.com

Twitter/X: EvolvaTweets

Top Investors: Wellington Partners, Centers for Disease Control and Prevention, Swisscom Ventures, Novartis Venture Fund, Astellas Venture Management

Description:

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients. Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small-molecule drugs and other compounds. In particular, their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches. The company is headquartered in Reinach, Switzerland.

Total Funding Amount:

$110M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Reinach, Aargau, Switzerland

Founded Date:

2004-01-01

Contact Email:

info(AT)evolva.com

Founders:

Alexandra SantAna Sorensen, Neil Goldsmith, Soren V.S. Nielsen

Number of Employees:

51-100

Last Funding Date:

2022-10-21

IPO Status:

Public

Industries:

© 2025 bioDAO.ai